Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 227 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Integrated Treatment Clear all

Conditions: HIV Prevention
Interventions: Integrated treatment program, Treatment as Usual; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Study Focusing on Integrated Versus Non-integrated Psychiatric Care in, Opioid-dependent and Methadone Treated Patients With Other Psychiatric, Diagnoses
Interventions: Counseling compliance; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use Disorder, Cannabis Use Disorder
Interventions: InTEGRA, MET/CBT; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 21 Years
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Farmington, Connecticut • Boston, Massachusetts

Conditions: Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD), Comorbidity, Trauma and Stressor Related Disorders
Interventions: Massed Prolonged Exposure Therapy (M-PE), Standard outpatient SUD care; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Prostate Cancer, Prostate Adenocarcinoma
Interventions: Hypofractionated Radiation Therapy; Radiation
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prostate Cancer
Interventions: PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC, Stereotactic Body Radiation Therapy (SBRT); Drug · Radiation
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years to 90 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma
Interventions: Cabazitaxel, Prednisone; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older · Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Hepatitis C
Interventions: Telemedicine; Other
Lead sponsor: Andrew Talal; Other
Eligibility: 18 Years and older
Enrollment: 602 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent
Interventions: ETBX-011, GI-4000, haNK for infusion, avelumab, Capecitabine, Cyclophosphamide, 5-Fluorouracil, Leucovorin, nab-Paclitaxel, Sorafenib, SBRT, Aldoxorubicin hydrochloride, ETBX-051, ETBX-061, GI-6207, GI-6301, Cetuximab, N-803; Biological · Drug · Procedure
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: El Segundo, California

Conditions: Stroke
Interventions: CARE-CITE, Standard of care; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 21 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chronic Pain, Depression
Interventions: Repetitive Transcranial Magnetic Stimulation, Acceptance and Commitment Therapy; Device · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Smoking, Anxiety Disorders, Depression Disorders
Interventions: Nicotine Patch, Depression and Anxiety Smoking Cessation Treatment, Educational-Support Psychotherapy; Drug · Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bipolar Disorder
Interventions: CARE; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Cranston, Rhode Island • Providence, Rhode Island

Conditions: Mood Disorders in Children and Adolescents
Interventions: Family-based treatment; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 10 Years to 18 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Adenocarcinoma of the Prostate
Interventions: HR-A, HR-B; Radiation
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Triple Negative Breast Cancer
Interventions: Aldoxorubicin HCl, N-803, ETBX-011, ETBX-051, ETBX-061, GI-4000, GI-6207, GI-6301, haNK for Infusion, avelumab, bevacizumab, Capecitabine, Cisplatin, Cyclophosphamide, 5-Fluorouracil, Leucovorin, nab-Paclitaxel, SBRT; Drug · Biological · Procedure
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: El Segundo, California

Conditions: Fatigue After Adjuvant Breast Cancer Treatment
Interventions: 10 week behavioral intervention program; Behavioral
Lead sponsor: Mercy Medical Center; Other
Eligibility: Not listed
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: CARE-CITE Education Program, Traditional Education, Constraint-Induced Movement Therapy (CIMT); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Smoking, Tobacco
Interventions: MASP app + NRT, QuitGuide app + NRT; Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma • Houston, Texas

Conditions: Mental Health Issue, HIV, Substance Use
Interventions: Single Session Narrative Therapy; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Bipolar Disorder
Interventions: CARE, Treatment As Usual; Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Cranston, Rhode Island • Providence, Rhode Island

Conditions: Diabetic Peripheral Neuropathic Pain (DPN)
Interventions: Implantable SCS with Closed Loop mechanism; Device
Lead sponsor: TriCity Research Center; Industry
Eligibility: 19 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Grand Island, Nebraska

Conditions: Cancer Pain, Opioid Use, Cognitive Behavior Therapy
Interventions: Cognitive Behavioral Therapy for pain; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Substance Use Disorders
Interventions: Voucher Reinforcement, Standard Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth

Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Project COMET: Massed Prolonged Exposure for PTSD and SUD

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals

QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Carepartner Collaborative Integrated Therapy in Sub-Acute Stroke

Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy

Smoking Cessation for Depression and Anxiety Treatment

Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial

Integrated Treatment for Youth With Mood Disorders

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

An Intervention to Decrease Fatigue Among Breast Cancer Survivors

Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke

Smoking, Stress, and Mobile Technology

Single Session Narrative Therapy Study

Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Pilot RCT

Medtronic Inceptiv™ Closed-Loop DTM Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy

Psychological Intervention Using Smartphone Technology to Alleviate Malignant Pain

Treatment for Psychological and Drug Abuse Problems